Mutagenic properties of cis-plantinum(II)diammino-dichloride in Escherichia coli.
cis-Platinum (II)diamminodichloride (PDD), an anti-tumor agent, induced auxotrophic mutations in Escherichia coli, some of which were reverted to prototrophy by exposure to PDD, 2-aminopurine (2-AP), and N-methyl-N'-nitro-N-mitrosoguanidine (NTG), but not ICR derivatives. Similarly, various 2-AT-, NTG-, and ultraviolet light-induced auxotrophs were reverted to prototrophy by PDD. Some PDD-induced auxotrophs carried nonsense mutations and others could be phenotypically suppressed growth with streptomycin. Although these findings suggest that PDD promotes base substitutions, this mutagen may also cause base subtractions because (like NTG) it induced, at reduced frequency, reversion to prototrophy of certain ICR-induced auxotrophs. Isomeric trans-platinum (II)diamminodichloride, which lacks anti-tumor activity, was an ineffective mutagen. Near-optimal conditions for PDD-induced mutagenesis entailed prolonged cultivation with low levels of mutagen where the frequency of forward mutation to auxotrophy was 10-3 and that of a selected trp isolate to prototrophy was 10-2.
D000166:Acridines / Q000494:pharmacology; D000225:Adenine / Q000494:pharmacology; D001483:Base Sequence; D002945:Cisplatin / Q000494:pharmacology*; D004926:Escherichia coli / Q000187:drug effects* / Q000528:radiation effects; D005827:Genetics, Microbial; D008967:Molecular Biology; D009153:Mutagens / Q000494:pharmacology*; D009154:Mutation; D009604:Nitrosoguanidines / Q000494:pharmacology; D011336:Probability; D011831:Radiation Genetics; D013307:Streptomycin / Q000494:pharmacology; D013489:Suppression, Genetic; D014466:Ultraviolet Rays
D000166:Acridines; D009153:Mutagens; D009604:Nitrosoguanidines; D000225:Adenine; D002945:Cisplatin; D013307:Streptomycin